High materiality8/10
Phreesia Analysts Raise Their Forecasts After Q2 Results
Why it may matterVerify against the original reporting
Phreesia's earnings beat expectations and significant sales guidance suggest strong fundamentals.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Phreesia reported earnings of 1 cent, beating estimates of a 6 cent loss. Quarterly sales reached $117.255 million, surpassing expectations of $116.526 million. Phreesia confirmed FY2026 sales guidance between $472 million and $482 million. CEO announced acquisition of AccessOne to enhance healthcare receivable financing solutions. Analysts have raised price targets, indicating continued optimism despite a recent share dip.
- Phreesia reported earnings of 1 cent, beating estimates of a 6 cent loss.
- Quarterly sales reached $117.255 million, surpassing expectations of $116.526 million.
- Phreesia confirmed FY2026 sales guidance between $472 million and $482 million.
- CEO announced acquisition of AccessOne to enhance healthcare receivable financing solutions.
- Analysts have raised price targets, indicating continued optimism despite a recent share dip.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.